Acurx Pharmaceuticals (ACXP) Tops Q1 EPS by 27c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.11), $0.27 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Texas Pacific Land agrees to supply land and water to Chevron power project
• Trump administration to offer $17.5 billion for nuclear reactors